Rea Federico, Ronco Raffaella, Pedretti Roberto F E, Merlino Luca, Corrao Giovanni
National Center for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
National Center for Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Int J Cardiol. 2020 Nov 1;318:14-20. doi: 10.1016/j.ijcard.2020.06.017. Epub 2020 Jun 25.
Patients who experience a hospital admission for acute coronary syndromes (ACS) exhibit poor prognosis over the years. The purposes of this study were to evaluate the real-world patterns of out-of-hospital practice in the management of ACS patients and to assess their impact on the risk of selected outcomes.
The cohort of 87,530 residents in the Lombardy Region (Italy) who were newly hospitalised for ACS during 2011-2015 was followed until 2018. Exposure to medical treatment including use of selected drugs, diagnostic procedures and laboratory tests was recorded. The main outcome of interest was re-hospitalisation for cardiovascular (CV) outcomes. Proportional hazards models were fitted to estimate hazard ratio, and 95% confidence intervals (CI), for the exposure-outcome association. Analyses were stratified according to the ACS type.
The cumulative incidence of re-hospitalisation for CV disease was 33%, 42% and 38% at 5 years after index discharge among STEMI, NSTEMI and unstable angina patients. Within one year from index discharge, between 70% and 80% of patients had at least a prescription of statins, beta-blockers and renin-angiotensin-system blocking agents, underwent ECG and lipid profile examination, and had a cardiologic examination. One patient in five underwent cardiac rehabilitation. Compared with patients who did not adhere to healthcare recommendations, the risk of CV hospital readmission was reduced from 10% (95% CI: 4%-10%) to 23% (12%-32%) among patients who underwent lipid profile examinations and who experienced cardiac rehabilitation.
Close out-of-hospital healthcare must be considered the cornerstone for improving the long-term prognosis of ACS patients.
因急性冠状动脉综合征(ACS)住院的患者多年来预后较差。本研究的目的是评估ACS患者院外管理的实际模式,并评估其对选定结局风险的影响。
对2011年至2015年期间在意大利伦巴第地区首次因ACS住院的87530名居民进行队列研究,随访至2018年。记录其接受的包括使用选定药物、诊断程序和实验室检查在内的医疗治疗情况。主要关注的结局是因心血管(CV)结局再次住院。采用比例风险模型来估计暴露-结局关联的风险比及95%置信区间(CI)。分析按ACS类型进行分层。
ST段抬高型心肌梗死(STEMI)、非ST段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛患者出院后5年因心血管疾病再次住院的累积发生率分别为33%、42%和38%。在出院后的一年内,70%至80%的患者至少接受过他汀类药物、β受体阻滞剂和肾素-血管紧张素系统阻断剂的处方治疗,接受过心电图和血脂检查,并进行过心脏检查。五分之一的患者接受了心脏康复治疗。与未遵循医疗建议的患者相比,接受血脂检查和心脏康复治疗的患者心血管疾病再次住院的风险从10%(95%CI:4%-10%)降至23%(12%-32%)。
必须将密切的院外医疗保健视为改善ACS患者长期预后的基石。